HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The protease inhibitor treatment of the disseminated intravascular coagulation syndrome in patients with liver cirrhosis].

Abstract
The results of the treatment of the syndrome of disseminated intravascular coagulopathy (DIC) in 41 patients with liver cirrhosis are reported. A relation between the severity of the liver impairment and the degree of the increase of the fibrin split products (FSP) was established. FSP above 100 micrograms/ml were found in patients with III class liver failure according to Child-Turcotte-Pugh and rating above 6.5 according to Z. KrÅ­stev. The administration of 30,000-60,000 U of the protease inhibitor contrykal led to mastering of the hemorrhagic diathesis in 19 of 21 patients (group A). The increased FSP in the serum fell (chi 2 = 5.79; p less than 0.001). In contrast, the administration of PAMBA and styptanon did not affect the hemorrhagic diathesis and DIC syndrome in 16 of 20 other patients (group B--chi 3 = 20.54; p less than 0.001). The authors recommend protease inhibitors as the treatment of choice of DIC syndrome in liver cirrhosis. Only in case of lack of effect should heparin be added.
AuthorsL Mateva, O Donkova
JournalVutreshni bolesti (Vutr Boles) Vol. 30 Issue 2 Pg. 105-10 ( 1991) ISSN: 0506-2772 [Print] Bulgaria
Vernacular TitleLechenie s proteazni inkhibitori na sindroma na diseminirana intravazalna koagulatsiia pri bolni s chernodrobna tsiroza.
PMID1716395 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antifibrinolytic Agents
  • Protease Inhibitors
  • para-Aminobenzoates
  • 4-aminomethylbenzoic acid
  • Aprotinin
  • estriol succinate
  • Estriol
  • 4-Aminobenzoic Acid
Topics
  • 4-Aminobenzoic Acid (therapeutic use)
  • Antifibrinolytic Agents (therapeutic use)
  • Aprotinin (therapeutic use)
  • Disseminated Intravascular Coagulation (drug therapy, etiology)
  • Drug Evaluation
  • Estriol (therapeutic use)
  • Humans
  • Liver Cirrhosis (complications, drug therapy)
  • Protease Inhibitors (therapeutic use)
  • para-Aminobenzoates

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: